Merrimack Pharm (MACK) Earnings
|
Expand Research on MACK
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -45.1% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +12.2% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/20/24 | Q124 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/13/24 | Q124 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/9/24 | Q124 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/6/24 | Q423 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/9/23 | Q323 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/10/23 | Q223 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
8/3/23  |
Q223 | -$0.03 | N/A | N/A | N/A | N/A | N/A |  | | Details | |
| 5/11/23 | Q123 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
